WASHINGTON (AP) — COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday.

FDA halts use of antibody drugs that don't work vs. omicron - Victoria Times Colonist 

Remdesivir usage continues.

Might be a good case for using ABL given that supply is short for Pfizer and Merck pills.  Will likely all depend on timing of when results come out, Phase 3 trial, etc.  Would be great if Morocco, other African/Middle East countries approved use of ABL from a great Phase2B trial rather than waiting for Phase3 in the US.  Could that be the reason for some of these "strange" arrangements?  Who knows.

masila